Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2017 October;65(5) > Minerva Cardioangiologica 2017 October;65(5):504-15

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

REVIEW  FUNCTIONAL TRICUSPID REGURGITATION: FROM PATHOPHYSIOLOGY TO THE NOVEL PERCUTANEOUS APPROACHES 

Minerva Cardioangiologica 2017 October;65(5):504-15

DOI: 10.23736/S0026-4725.17.04359-6

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Transcatheter treatment of functional tricuspid regurgitation: preliminary experiences

Luis ASMARATS, Rishi PURI, Josep RODÉS-CABAU

Quebec Heart and Lung Institute, Laval University, Quebec City, QC, Canada


PDF


Tricuspid regurgitation (TR) is a common finding in patients with left-sided valvular or myocardial disease. However, many patients with severe symptomatic TR are deemed inoperable or at high surgical risk, often due to comorbidities and the need for redo sternotomy. Thus, despite the poor prognosis associated with this condition, few patients undergo isolated surgical tricuspid valve repair. Therefore, there is an unmet clinical need for less invasive therapeutic options for these patients. In recent times, several transcatheter therapies have emerged for treating TR, with promising safety and preliminary efficacy results. In this review, we describe the main features of and clinical results associated with such devices, and describe the ongoing and future studies in the field.


KEY WORDS: Cardiac catheterization - Tricuspid valve - Tricuspid valve insufficiency

top of page